Today's thermal therapy: Not your father's hyperthermia: Challenges and opportunities in application of hyperthermia for the 21st century cancer patient

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 1, 2010, Pages 96-100

  Hurwitz, Mark D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hyperthermia; Review; Thermal therapy

Indexed keywords

BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; HUMAN; HYPERTHERMIA; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; RECTUM CANCER; REVIEW; TREATMENT PLANNING; UTERINE CERVIX CANCER;

CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS;

EID: 76749158379     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181817a75     Document Type: Review

References (44)

1. Dewey WC, Hopwood LE, Sapareto LA, et al. Cellular response to combinations of hyperthermia and radiation. Radiology. 1977;123:463-474.
2. Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell cycle of Chinese hamster cells in vitro. Int J Radiat Biol. 1971;19:467-477.
3. Kim J, Hahn EW. Clinical and biological studies of localized hyperthermia. Cancer Res. 1979;39:2258-2261.
4. Gerweck LE, Nygaard TG, Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Res. 1979;39:966-972.
5. Hahn GM, Shiu C. Adaptation to low pH modifies thermal and thermochemical responses of mammalian cells. Int J Hyperther. 1986;2:379-387.
6. Henle KJ, Leeper DB. Combination of hyperthermia (40°, 45° C) with radiation. Radiology. 1976;121:451-454.
7. Kano E. Hyperthermia and drugs. In: Overgaard J, ed. Hyperthermic Oncology. London, Uk: Taylor & Francis; 1985:277-282.
8. Eddy HA. Alterations in tumor microvasculature during hyperthermia. Radiology. 1980;137:515-521.
9. Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44(suppl 10):S4721-S4730.
10. Franceschi C. Cell proliferation, cell death and aging. Aging (Milano). 1989;1:3-15.
11. Fuller KJ, Issels RD, Slosman DO, et al. Cancer and the heat shock response. Eur J Cancer. 1994;30A:1884-1891.
12. Arya R, Mallik M, Lakhotia SC. Heat shock genes-integrating cell survival and death. J Biosci. 2007;32:595-610.
13. McKenzie SL, Henikoff S, Meselson M. Localization of RNA from heatinduced polysomes at puff sites in Drosophila melanogaster. Proc Natl Acad Sci USA. 1975;72:1117-1121.
14. Lindquist S, Craig EA. The heat shock proteins. Annu Rev Genet. 1988;22: 631-677.
15. Beckman RP, Mizzen LA, Welch WJ. Interaction of HSP70 with newly synthesized proteins; implications for protein folding and assembly. Science. 1990;248:850-854.
16. Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992;355:33-45.
17. Netzer WF, Hartl FU. Protein folding in the cytosol: chaperone-in- dependent and independent mechanisms. Trends Biochem Sci. 1998;23:68-74.
18. Asea A, Kraeft SK, Kurt-Jones EA, et al. . HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-442.
19. Srivastava PK, Maki RG. Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol. 1991;167:109-123.
20. Udono H, Srivastava PK. Comparison of tumor-specific immunogenicities of stressinduced proteins gp96, hsp90, and hsp70. J Immunol. 1994;152:5398-5403.
21. Udono H, Levy DL Srivastava PK. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8- T cells in vivo. Proc Natl Acad Sci USA. 1994;91:3077-3081.
22. Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 1993;178:1391-1396.
23. Sydor JR, Normant E, Pien CS, et al. Development of 17-allylamino-17- demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90. Proc Natl Acad Sci USA. 2006;103:17408-17413.
24. van der Poel HG, Hanrahan C, Zhong H, et al. Rapamycin induces Smad activity in prostate cancer cell lines. Urol Res. 2003;30:380-386.
25. Powers MW, Workman P. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer. 2006;13(suppl 1):S125-S135.
26. Xiao L, Lu X, Ruden DM. Effectiveness of hsp90 inhibitors as anti-cancer drugs. Mini Rev Med Chem. 2006;6:1137-1143.
27. Asea A, Ara G, Teicher BA, et al. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int J Hyperthermia. 2001;17:347-356.
28. Jones EL, Zhao MJ, Stevenson MA, et al. The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. Int J Hyperthermia. 2004;20:835-849.
29. Juang T, Neuman D, Schlorff J, et al. Construction of a conformal water bolus vest applicator for hyperthermia treatment of superficial skin cancer. Conf Proc IEEE Eng Med Biol Soc. 2004;5:3467-3470.
30. Lilly MB, Brezovich IA, Atkinson WJ. Hyperthermia induction with thermally self-regulated ferromagnetic implants. Radiology. 1985;154:243-244.
31. Meijer JG, van Wieringen N, Koedooder C, et al. The development of PdNi thermoseeds for interstitial hyperthermia. Med Phys. 1995;22:101-104.
32. Wust P, Gneveckow U, Johannsen M, et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia. 2006;22:673-685.
33. Wust P, Cho CH, Hildebrandt B, et al. Thermal monitoring: invasive, minimalinvasive and non-invasive approaches. Int J Hyperthermia. 2006;22:255-262.
34. Gellermann J, Hildebrandt B, Issels R, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer. 2006;107:1373-1382.
35. Perez CA, Pajak T, Emami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol. 1991;14:133-141.
36. Emami B, Scott C, Perez CA, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys. 1996;34:1097-1104.
37. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35:731-744.
38. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23:3079-3085.
39. van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355:1119-1125.
40. Sneed PK, Stauffer PR, McDermott MW, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost-/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40:287-295.
41. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1994;28:163-169.
42. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia. 1996;12:3-20.
43. Needham D, Anyarambhatla G, Kong G, et al. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000;60:1197-1201.
44. Horkan C, Dalal K, Coderre JA, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology. 2005;235:81-88.